GlassScriptPhysician profile
William M Sugarmann
NPI 1982717880
$902.96
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $190 · 2020: $57.96 · 2021: $127 · 2022: $277 · 2023: $225 · 2024: $24.99.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $250.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $250.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $165.34 | 2019-2022 | |
| Endologix LLC | $105.10 | 2021-2022 | |
| Boston Scientific Corporation | $93.70 | 2021-2024 | Varithena Administration Pack |
| Kowa Pharmaceuticals America, INC. | $76.88 | 2022-2023 | Seglentis |
| Janssen Pharmaceuticals, INC | $61.61 | 2019 | |
| Bard Peripheral Vascular, INC. | $50.46 | 2019-2023 | Venclose Maven Catheter |
| Davol INC. | $48.23 | 2020-2022 | |
| Smith+Nephew, INC. | $47.44 | 2019-2023 | Collagenase Santyl |
| Tela Bio, INC. | $37.25 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Teleflex LLC | $36.03 | 2022-2023 | Arrow |
| Myriad Genetic Laboratories, INC. | $19.78 | 2023 | Myrisk |
| Angiodynamics, INC. | $18.93 | 2023 | Venacure 1470 Pro |
| Heron Therapeutics, INC. | $18.21 | 2021 | |
| Baudax Bio INC. | $18.08 | 2021 | |
| Tactile Systems Technology INC | $17.22 | 2023 | Entre Plus, Flexitouch Plus |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $16.99 | 2022 | |
| Acell, INC. | $16.44 | 2019 | |
| Veryan Medical Incorporated | $15.94 | 2021 | |
| Olympus America INC. | $14.00 | 2019 | |
| Pfizer INC. | $13.13 | 2020 | |
| Kci USA, INC. | $12.20 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Sugarmann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.